Precision Business Insights
Portfolio

 

Cartilage Repair/Regeneration Market

: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2014-2018 and Forecast 2019-2025

Global Cartilage Repair/Regeneration Market By Modality (Non Cell Based, Cell Based), By Application (Fibrocartilage, Hyaline Cartilage), By Treatment Type (Intrinsic Repair Stimulus, Palliative Treatment) and Geography

 

Market Outline: Cartilage Repair/Regeneration Market

Cartilage is a colossally strong and fibrous flexible tissue which is present at many in major parts of the body serving many purposes. The hyaline cartilage which is present at a joint referred to the articular cartilage. In case of injury, ageing or diseases such as rheumatoid arthritis, osteoarthritis causes painful friction or injury to the cartilage. Because of not having blood vessels, cartilage does not heal itself well. So there is a need for the treatment options to aid the regeneration or repair the cartilage.

Global Cartilage Repair/Regeneration Market was valued at US $ XX Mn and expected to grow at XX% Compound Annual Growth Rate (CAGR) over 2018 to 2024.

 

Market Dynamics: Cartilage Repair/Regeneration Market

Global cartilage repair/regeneration market primarily driven by the rise in the prevalence of bone and joint disorders such as osteoporosis, arthritis and ageing population worldwide. Furthermore, lifestyle changes, increase in prevalence of diabetes and number of road accidents projected to boost the market growth over the forecast period. Moreover, advent of the new cell based technologies and extensive use micro fracture techniques aiding the surgical procedures expected to bolster the market revenue in near future. However, high cost of the procedures, drugs are expected to hamper the market growth over the forecast period.

 

Regional Analysis:  Cartilage Repair/Regeneration Market

Geographically, cartilage repair/regeneration market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. North America cartilage repair/ regeneration market expected to grow at notable growth rate owing to rise in prevalence of musculoskeletal disorder, obesity, especially in Canada and U.S. Asia Pacific cartilage repair/regeneration market expected to have the lucrative market growth over the forecast period owing to the presence large pool of patients suffering with diabetes, change in lifestyles and developing healthcare infrastructure. For instance, International Diabetes Federation has reported about 109.6 million cases in China, nearly 7.2 million cases in Japan and 1millian in Australia. Europe cartilage repair/regeneration market expected to have the significant growth rate owing to rise in prevalence of osteoporosis and other bone related diseases, ageing population and advancements in healthcare technologies. According to National Health Services (NHS) Report osteoporosis affects about 3 million people every year.

 

Market Scope: Cartilage Repair/Regeneration Market

Global cartilage repair/regeneration market is segmented based on the modality, application, treatment and geography

Based on modality, the market is segmented into the following:

  • Non Cell Based
  • Cell Based

Based on application, the market is segmented into the following:

  • Fibrocartilage
  • Hyaline Cartilage

Based on treatment type, the market is segmented into following:

  • Intrinsic Repair Stimulus
  • Palliative Treatment

Based on region, the market is segmented into following:

  • North America
  • Latin America
  • Asia Pacific
  • Europe
  • Middle East and Africa (MEA)

 

Competition Assessment: Cartilage Repair/Regeneration Market

Some of the players in the global cartilage repair/regeneration Market include:

  • Braun Melsungen AG (Germany)
  • DePuy Synthes (Johnson& Johnson Services Inc.) (U.S.)
  • Stryker Corporation (U.S.)
  • Zimmer Biomet (U.S.)
  • Arthrex Inc. (Germany)
  • Collagen Solutions (U.K)
  • Osiris Therapeutics Inc. (U.S.)

 

Notable Market Developments: Cartilage Repair/Regeneration Market

  • In Febrauray 2012, Zimmer Biomet has launched achondrofixosteochondral allograft for treatment of cartilage lesions in U.S.
    

A complementary 2hrs free facility through which report buyers can interact with our pool of experienced analysts for any report related queries, clarifications or additional data requirements

OR

CALL US ON : 123456789